Cargando…

Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications

Gastrointestinal cancer is a leading cause of cancer-related mortality and remains a major challenge for cancer treatment. Despite the combined administration of modern surgical techniques and chemoradiotherapy (CRT), the overall 5-year survival rate of gastrointestinal cancer patients in advanced s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ding-Kang, Zuo, Qian, He, Qing-Yu, Li, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383067/ https://www.ncbi.nlm.nih.gov/pubmed/34447376 http://dx.doi.org/10.3389/fimmu.2021.705999

Ejemplares similares

CD73's Potential as an Immunotherapy Target in Gastrointestinal Cancers
por: Harvey, Jerry B., et al.
Publicado: (2020)

Editorial: Gastrointestinal cancer immunotherapy: from drug resistance mechanisms to overcoming strategies
por: Shi, Tao, et al.
Publicado: (2023)

Immunotherapy resistance in esophageal cancer: Possible mechanisms and clinical implications
por: Fang, Pinhao, et al.
Publicado: (2022)

Editorial: Development and Potential Mechanisms of Low Molecular Weight Drugs for Cancer Immunotherapy
por: Gao, Yanfeng, et al.
Publicado: (2022)

Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy
por: Hua, Hanju, et al.
Publicado: (2023)

Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications
por: Wang, Man, et al.
Publicado: (2023)

Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer
por: Zheng, Yiwen, et al.
Publicado: (2023)

Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy
por: Tang, Qi, et al.
Publicado: (2023)

Editorial: Combinational immunotherapy of cancer: novel targets, mechanisms, and strategies
por: Nan, Yanyang, et al.
Publicado: (2023)

Landscapes and mechanisms of CD8(+) T cell exhaustion in gastrointestinal cancer
por: Ding, Jia-Tong, et al.
Publicado: (2023)

Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy
por: Ye, Zu, et al.
Publicado: (2021)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer
por: Ni, Ling
Publicado: (2022)

Tumor Microenvironment Evaluation for Gastrointestinal Cancer in the Era of Immunotherapy and Machine Learning
por: Ye, Zilan, et al.
Publicado: (2022)

Editorial: Tumor microenvironment, immunotherapy, and drug resistance in breast and gastrointestinal cancer
por: Deng, Xinpei, et al.
Publicado: (2023)

Dickkopf-1: A Promising Target for Cancer Immunotherapy
por: Chu, Hang Yin, et al.
Publicado: (2021)

The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
por: Paul, Sourav, et al.
Publicado: (2017)

Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy
por: Wei, Qi, et al.
Publicado: (2022)

Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms
por: Chandra, Janin, et al.
Publicado: (2022)

Editorial: Novel Strategies for Cancer Immunotherapy: Targeting Immune-Mediated Suppressive Mechanisms
por: Lafont, Virginie, et al.
Publicado: (2021)

SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy
por: Farhangnia, Pooya, et al.
Publicado: (2023)

Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors
por: Roulleaux Dugage, Matthieu, et al.
Publicado: (2021)

Neoadjuvant immunotherapy for resectable esophageal cancer: A review
por: Li, Qing, et al.
Publicado: (2022)

Editorial: Targeting Metabolism in Cancer Immunotherapy
por: Roszik, Jason, et al.
Publicado: (2018)

Computational Recognition of a Regulatory T-cell-specific Signature With Potential Implications in Prognosis, Immunotherapy, and Therapeutic Resistance of Prostate Cancer
por: Ju, Mingyi, et al.
Publicado: (2022)

Natural Polyphenols as Targeted Modulators in Colon Cancer: Molecular Mechanisms and Applications
por: Long, Jing, et al.
Publicado: (2021)

Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
por: Zhao, Jianan, et al.
Publicado: (2021)

Damage-associated molecular patterns and sensing receptors based molecular subtypes in malignant pleural mesothelioma and implications for immunotherapy
por: Liu, Zheng, et al.
Publicado: (2023)

Platelet-Mediated Protection of Cancer Cells From Immune Surveillance – Possible Implications for Cancer Immunotherapy
por: Schmied, Laurent, et al.
Publicado: (2021)

Molecular Recognition of Gangliosides and Their Potential for Cancer Immunotherapies
por: Krengel, Ute, et al.
Publicado: (2014)

Cancer Cell-Intrinsic PD-1 and Implications in Combinatorial Immunotherapy
por: Yao, Han, et al.
Publicado: (2018)

Integration of local and systemic immunity in ovarian cancer: Implications for immunotherapy
por: Rajtak, Alicja, et al.
Publicado: (2022)

Neoadjuvant SBRT combined with immunotherapy in NSCLC: from mechanisms to therapy
por: Shi, Yanhong, et al.
Publicado: (2023)

Targeting PARP1 to Enhance Anticancer Checkpoint Immunotherapy Response: Rationale and Clinical Implications
por: Wanderley, Carlos Wagner S., et al.
Publicado: (2022)

Editorial: Community series in combinational immunotherapy of cancer: novel targets, mechanisms, and strategies, volume II
por: Xu, Caili, et al.
Publicado: (2023)

Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters
por: Wang, Shuyue, et al.
Publicado: (2021)

Mechanism and strategies of immunotherapy resistance in colorectal cancer
por: Shan, Jiqi, et al.
Publicado: (2022)

Prognostic value of fatty acid metabolism-related genes in colorectal cancer and their potential implications for immunotherapy
por: Huang, Xi, et al.
Publicado: (2023)

Targeting Resident Memory T Cells for Cancer Immunotherapy
por: Blanc, Charlotte, et al.
Publicado: (2018)

Complement System: An Immunotherapy Target in Colorectal Cancer
por: Talaat, Iman M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1fajvtor3dh6a1bvcra327qfa1